Rhythm Pharmaceuticals, Inc.
RYTM
$115.48
-$0.54-0.47%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -205.35M | -202.68M | -196.54M | -192.33M | -183.10M |
| Total Depreciation and Amortization | 1.08M | 1.21M | 1.34M | 1.45M | 1.53M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 102.86M | 92.03M | 80.49M | 71.82M | 62.32M |
| Change in Net Operating Assets | -3.94M | -10.07M | -968.00K | 9.93M | 11.53M |
| Cash from Operations | -105.35M | -119.51M | -115.68M | -109.13M | -107.72M |
| Capital Expenditure | -953.00K | -953.00K | -953.00K | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -143.98M | -103.96M | -136.20M | -146.34M | 9.19M |
| Cash from Investing | -144.94M | -104.91M | -137.15M | -146.34M | 9.19M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 211.67M | 208.11M | 237.88M | 277.56M | 88.52M |
| Repurchase of Common Stock | -9.72M | -8.46M | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | 0.00 | 0.00 |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -22.17M | -19.59M | -19.92M | -18.33M | -16.09M |
| Cash from Financing | 179.79M | 180.06M | 217.96M | 259.24M | 72.43M |
| Foreign Exchange rate Adjustments | 599.00K | 537.00K | 87.00K | 1.00M | 93.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | 1.00K | 0.00 |
| Net Change in Cash | -69.90M | -43.82M | -34.78M | 4.77M | -26.02M |